ELII: Multi-pathogen antiviral medical countermeasure deploying FDA approved drug against Orthopoxvirus

Project: Other project

StatusFinished
Effective start/end date2/24/1410/31/15

Funding

  • Inhibikase Therapeutics Inc.: $660,687.00